Skip to main content
PMC home page
AMB Express logoLink to AMB Express
. 2020 Mar 20;10:57. doi: 10.1186/s13568-020-00987-8

Anserine and glucosamine supplementation attenuates the levels of inflammatory markers in rats with rheumatoid arthritis

Jiang Minghao Zhao 1,#, Xiang Chen 1,#, Ke Cheng 1, Qingming Shi 1,✉, Kun Peng 1,✉
PMCID: PMC7083984  PMID: 32198574

Abstract

Rheumatoid arthritis (RA) is an autoimmune disorder that affects the joint synovium. Anserine is a functional dipeptide containing methylhistidine and β-alanine, and is present in the brain and skeletal muscle of birds and mammals. Glucosamine is an amino sugar used in the synthesis of glycosylated proteins and lipids. We evaluated the effects of anserine and glucosamine on RA. Rats were assigned into the control group, RA group, anserine group (1 mg/kg), glucosamine group (200 mg/kg), or anserine plus glucosamine group (anserine, 1 mg/kg + glucosamine, 200 mg/kg). Treatment was continued for 45 consecutive days and was administered orally. The serum levels of catalase, glutathione peroxidase (Gpx), superoxide dismutase (SOD), reduced glutathione (GSH), lipid peroxidation, uric acid, nitric oxide, ceruloplasmin, zinc, copper, prostaglandin E2 (PGE2), matrix metalloproteinase (MMP)-3, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were assayed. The mRNA and protein levels of nuclear factor (NF)-κB and inducible nitric oxide synthase (iNOS) in synovial tissue were also determined. Anserine plus glucosamine significantly increased the catalase, SOD, Gpx, GSH, and zinc levels compared to the control, anserine, and glucosamine groups. Also, anserine plus glucosamine significantly reduced the PGE2, MMP-3, TNF-α, IL-1β, and IL-6 levels compared to the control, anserine, and glucosamine groups. Furthermore, anserine plus glucosamine significantly reduced the mRNA and protein levels of NF-κB and iNOS compared to the control, anserine, and glucosamine groups. Therefore, supplementation of anserine plus glucosamine shows therapeutic potential for RA.

Keywords: Rheumatoid arthritis, Anserine, Glucosamine, Antioxidant, Rats

Introduction

Rheumatoid arthritis (RA) is an autoimmune disorder that affects the joint synovium. Swelling, inflamed joints, stiffness, and pain are the primary symptoms of RA (Choudhary et al. 2018). However, the pathogenetic mechanisms of RA are unclear. Delaying joint function disability is the major therapeutic approach for RA (Wang et al. 2014). Verschueren et al. (2009) have reported the alteration in working situation, normalized physical function and predictors of remission in early rheumatoid arthritis. Researchers have reported the use of biologics in the treatment of rheumatoid arthritis (Curtis and Singh 2011). Liu and Pope (2003) reported that the pannus and hyperplastic synovial tissue erode bone tissue and articular cartilage. Nakamura et al. (2007) showed that tumor necrosis factor (TNF)-α, prostaglandin E2 (PGE2), nitric oxide (NO), interleukin (IL)-1, and matrix metalloproteinases (MMPs) are important articular components. Therefore, induction of apoptosis and inhibition of cell proliferation are the primary therapeutic approaches for RA.

Anserine is a functional dipeptide containing methylhistidine and β-alanine found in the brain and skeletal muscle of birds and mammals (Kubomura et al. 2010). Tanida et al. (2010) evaluated the impact of anserine on the blood pressure and renal sympathetic nerve activity in rats. Sugiyama et al. (2005) reported that anserine augments the antitumor activity of doxorubicin. Kaneko et al. (2017) showed that anserine improves spatial memory and neurovascular-unit dysfunction in a mouse model of Alzheimer’s disease. Kang et al. (2002) reported that anserine suppresses peroxyl radical-mediated modification of superoxide dismutase (SOD). Glucosamine is an amino sugar used in the synthesis of glycosylated proteins and lipids (Dai et al. 2018), which is produced using wheat, crustacean cytoskeletons, and corn as raw materials (Towheed et al. 2005). Glucosamine supplementation reduced the level of pain of osteoarthritic patients (Reginster et al. 2001). McAlindon et al. (2000) reported that glucosamine and chondroitin synergistically protect against osteoarthritis. Dai et al. (2018) showed that vitamin E and glucosamine exert a synergistic therapeutic effect against RA in a neonatal rat model. Thus, we evaluated the effect of anserine and glucosamine on RA.

Materials and methods

Rats and housing

Male albino Wistar strain rats (170–200 g) were purchased from the Animal House of the Department of Orthopaedics, The Second Affiliated Hospital of Nanchang University, No 1 minde road, Donghu district, Nanchang city, JiangXi province, China and maintained in rat cages under a 12/12 h light/dark cycle at 60 ± 5% relative humidity and 25 ± 0.5 °C. All procedures performed in studies involving animals were in accordance with the ethical standards of the Second Affiliated Hospital of Nanchang University at which the studies were conducted. Research proposal was approved on 03/02/2019.

Model of RA

RA was induced according to Dai et al. (2018; Wang et al. 2015). Briefly, complete Freund’s adjuvant was administered to the rats intradermally. Type II bovine collagen and complete Freund’s adjuvant were mixed at an equal ratio to prepare the adjuvant emulsion. The primary dose of emulsion (1 mg/ml) was administered to the rats intradermally, followed 3 weeks later by incomplete Freund’s adjuvant as a booster.

Group assignment

Rats were assigned into the normal control group, RA group, anserine (A1131, Sigma-Aldrich, Shanghai, China) group (1 mg/kg), glucosamine (Sigma-Aldrich) group (200 mg/kg), or anserine plus glucosamine (anserine, 1 mg/kg + glucosamine, 200 mg/kg) group. Treatment was continued for 45 consecutive days and was administered orally. Each group contained six rats.

Biochemical markers

At the end of treatment, rats were sacrificed following anesthetized by using 10% chloral hydrate. The blood was collected by cardiac puncture in a plain bottle, and from which serum was separated for the biochemical analysis. Then, rat was immediately dissected, and synovial tissues were excised and weighed. The serum levels of catalase, glutathione peroxidase (Gpx), SOD, and reduced glutathione (GSH) were determined as described previously (Weydert and Cullen 2010; Baydas et al. 2002). The serum lipid peroxidation level was measured as described elsewhere (Samarghandian et al. 2014). The serum levels of uric acid and nitric oxide (NO) were determined by calorimetric assay (Wu et al. 2018; Van Beezooijen et al. 1998). The serum levels of ceruloplasmin, zinc, copper, PGE2, MMP-3, TNF-α, IL-1β, and IL-6 were determined as described previously (Dai et al. 2018).

Reverse transcriptase-polymerase chain reaction (RT-PCR)

The mRNA and protein levels of nuclear factor (NF)-κB and inducible nitric oxide synthase (iNOS) in synovial tissue were determined according to Dai et al. (2018). Briefly, total RNA was isolated from synovial tissue and transcribed into cDNA, and NF-κB and iNOS mRNA was amplified using specific primers (Table 1).

Table 1.

List of primers used in real-time polymerase chain reaction (qRT-PCR)

S. no Gene name Sense primer Anti-sense primer
1 iNOS 5′-GTTCTCAAGGCACAGGTCTC-3′ 5′-GCAGGTCACTTATGTCACTTATC-3′
2 NF-κB 5′-GAAATTCCTGATCCAGACAAAAAC-3′ 5′-ATCACTTCAATGGCCTCTGTGTAG-3′
3 GAPDH 5′-TCCCTCAAGATTGTCAGCAA-3′ 5′-AGATCCACAACGGATACATT-3′
Open in a new tab

Western blotting

Synovial tissue proteins were resolved by sodium dodecyl sulfate–polyacrylamide gel electrophoresis, transferred onto a membrane, and incubated with antibodies against iNOS (Abcam, ab3523) and NF-κB (Abcam, ab16502) for 12 h. Finally, the blot was incubated with a horseradish peroxidase (HRP)-conjugated secondary antibody (ab6721, Abcam) for 60 min and the protein levels were assayed by enhanced chemiluminescence (ECL) (Zou et al. 2016).

Immunohistochemistry

At the end of the treatment, rats were anesthetized by 10% chloral hydrate, and sacrificed. The knee synoviums of their hind limbs were harvested and fixed in formalin for 24 h, and embedded in paraffin. Next, the sections were deparaffinized, and rehydrated in xylene and a graded alcohol series. Hydrogen peroxide (3%) was applied to inhibit endogenous peroxidase activity and bovine serum albumin (2%) to block non-specific binding. Synovial tissue was treated with anti-iNOS (Abcam, ab3523) and anti-NF-κB (Abcam, ab16502) antibodies overnight and incubated with an HRP-conjugated antibody for 1 h (Balic et al. 2011). The iNOS and NF-κB expression was analyzed using a confocal microscope (FV300, Olympus, Japan).

Statistical analysis

Values are mean ± standard deviation and were subjected to analysis of variance (ANOVA) with the Tukey post hoc test. The difference was taken as significant when P < 0.05.

Results

Biochemical marker levels in RA rats

We evaluated the effect of anserine and glucosamine on RA. The SOD, catalase, Gpx, and GSH levels were reduced by 63.6%, 74.2%, 73.3%, and 63.4%, respectively, in the RA group compared to the normal control group (Table 2, P < 0.05). Lipid peroxidation, NO, uric acid, ceruloplasmin, and copper were increased by 431.3# 288%, 200%, 126.7%, and 92.3%, respectively (Table 2, P < 0.05), while the zinc level was decreased by 158.3% (Table 2, P < 0.05). The MMP-3, PGE2, TNF-α, IL-1β, and IL-6 levels were increased by 328.6%, 251.3%, 68.9%, 126.7%, and 166.7%, respectively (Table 2, P < 0.05). The mRNA and protein levels of NF-κB and iNOS were also significantly increased (Figs. 1 and 2, P < 0.05).

Table 2.

Effect of anserine and glucosamine on the biochemical markers in rheumatoid arthritis induced rat model

Markers Normal control Control Anserine (1 mg/kg) Glucosamine (200 mg/kg) Anserine (1 mg/kg) + Glucosamine (200 mg/kg)
SOD (U/ml) 365.2 ± 21.4 133.1 ± 5.2*** 197.4 ± 7.5# 213.2 ± 11# 313.4 ± 16###
Catalase (U/ml) 13.2 ± 0.8 3.4 ± 0.18*** 5.9 ± 0.2# 6.2 ± 0.3# 10.6 ± 0.5###
Gpx (U/ml) 0.45 ± 0.01 0.12 ± 0.005*** 0.21 ± 0.02# 0.25 ± 0.01# 0.38 ± 0.01###
GSH (nmol/ml) 0.41 ± 0.03 0.15 ± 0.01*** 0.22 ± 0.01# 0.24 ± 0.01# 0.36 ± 0.02###
MDA (nmol/ml) 0.32 ± 0.01 1.7 ± 0.1*** 1.1 ± 0.06# 0.9 ± 0.05## 0.51 ± 0.03###
NO (ng/ml) 0.25 ± 0.02 0.97 ± 0.05*** 0.73 ± 0.05# 0.62 ± 0.07# 0.44 ± 0.08###
Uric acid (mg/ml) 0.23 ± 0.01 0.69 ± 0.03*** 0.52 ± 0.01# 0.54 ± 0.04# 0.35 ± 0.03###
Ceruloplasmin (mg/ml) 0.15 ± 0.01 0.34 ± 0.01*** 0.26 ± 0.01# 0.31 ± 0.01 0.17 ± 0.04##
Copper (µg/ml) 0.13 ± 0.01 0.25 ± 0.01** 0.23 ± 0.01 0.21 ± 0.01 0.17 ± 0.03#
Zinc (µg/ml) 0.31 ± 0.02 0.12 ± 0.01*** 0.15 ± 0.01 0.14 ± 0.01 0.24 ± 0.02##
MMP-3 (ng/ml) 52.5 ± 3.2 225 ± 15*** 171.3 ± 7.1# 156 ± 8# 81 ± 6.4###
PGE2 (pg/ml) 27.1 ± 1.2 95.2 ± 5*** 72.2 ± 3.4# 71.4 ± 4.5# 38.3 ± 2###
TNF-α (U/ml) 2.9 ± 0.12 4.9 ± 0.2*** 4.1 ± 0.1# 3.9 ± 0.13# 3.2 ± 0.2##
IL-1β (U/ml) 1.5 ± 0.01 3.4 ± 0.2*** 2.7 ± 0.05# 2.5 ± 0.12# 1.8 ± 0.05###
IL-6 (U/ml) 2.7 ± 0.12 7.2 ± 0.21*** 6.1 ± 0.2# 5.1 ± 0.15# 3.3 ± 0.12##
Open in a new tab

***P < 0.001, #P < 0.05, ##P < 0.05 and ###P < 0.05

Fig. 1.

Fig. 1

Open in a new tab

Anserine plus glucosamine supplementation reduced the mRNA and protein levels of NF-κB and iNOS in synovial tissue. a mRNA levels of NF-κB and iNOS. b Western blots of NF-κB and iNOS. c Densitometric analysis of the data in b

Fig. 2.

Fig. 2

Open in a new tab

Anserine plus glucosamine supplementation reduced the protein levels of NF-κB and iNOS in synovial tissue. a Immunohistochemical analysis of NF-κB and iNOS. b Analysis of the protein levels in a. Scale bar is 100 µm

Effect of anserine on biochemical and molecular markers in RA rats

The SOD, catalase, Gpx, and GSH levels were increased by 48.3%, 73.5%, 75%, and 46.7%, respectively, in the anserine group compared to the control group (Table 2, P < 0.05). Lipid peroxidation, NO, uric acid, ceruloplasmin, and copper were reduced by 35.3%, 24.7%, 24.6%, 23.5%, and 8%, respectively, while the zinc level was increased by 25% (Table 2, P < 0.05). The MMP-3, PGE2, TNF-α, IL-1β, and IL-6 levels were reduced by 23.8%, 24.1%, 16.3%, 20.6%, and 15.3%, respectively (Table 2, P < 0.05). The mRNA levels of NF-κB and iNOS were reduced by 18.5% and 13% respectively, whereas protein levels of NF-κB and iNOS were reduced by > 9% compared to the control group (Figs. 1 and 2, P < 0.05).

Effect of glucosamine on biochemical and molecular markers in RA rats

The SOD, catalase, Gpx, and GSH levels were increased by 60.2%, 82.4%, 108.3%, and 60%, respectively, in the glucosamine group compared to the control group (Table 2, P < 0.05). Lipid peroxidation, NO, uric acid, ceruloplasmin, and copper were reduced by 47%, 36.1%, 21.7%, 8.8%, and 20%, respectively, while the zinc level was increased by 16.7% (Table 2, P < 0.05). The MMP-3, PGE2, TNF-α, IL-1β, and IL-6 levels were reduced by 30.7%, 25%, 20.4%, 26.5%, and 29.2%, respectively (Table 2, P < 0.05). The mRNA levels of NF-κB and iNOS were reduced by 25.9% and 17.4% respectively, whereas protein levels of NF-κB and iNOS were reduced by > 13% in the glucosamine group compared to the control group (Figs. 1 and 2, P < 0.05).

Synergistic effect of anserine plus glucosamine on biochemical and molecular markers in RA rats

The SOD, catalase, Gpx, and GSH levels were increased by 135.5%, 211.8%, 216.7%, and 140%, respectively, in the anserine plus glucosamine group compared to the control group (Table 2, P < 0.05). Lipid peroxidation, NO, uric acid, ceruloplasmin, and copper were reduced by 70%, 54.6%, 49.3%, 50%, and 32%, respectively, while the zinc level was increased by 100% (Table 2, P < 0.05). The MMP-3, PGE2, TNF-α, IL-1β, and IL-6 levels were significantly reduced in the anserine plus glucosamine group (Table 2, P < 0.05). The mRNA and protein levels of NF-κB and iNOS were also significantly reduced in the anserine plus glucosamine group compared to the control, anserine, and glucosamine groups (Figs. 1 and 2, P < 0.05).

Discussion

We evaluated the effect of anserine and glucosamine on RA. A low level of cellular antioxidants and increased production of free radicals are implicated in RA (van Vugt et al. 2008). A higher rate of membrane fatty acid oxidation results in elevated levels of lipid peroxyl radicals. Ozturk et al. (1999) reported that the rate of lipid peroxidation is higher in patients with RA compared to healthy persons. Anserine and glucosamine have free radical-scavenging activity and inhibit lipid peroxidation (Wu et al. 2003; Tiku et al. 2007). Supplementation of glucosamine with vitamin E reduced lipid peroxidation in neonatal rats (Dai et al. 2018). In this study, anserine plus glucosamine decreased the level of lipid peroxidation compared to anserine, glucosamine, and the control.

Oxidative injury and inflammation increase the level of prostaglandin (Bae et al. 2003). MMP-3 produced by synovium-lining cells activates pro-collagenases, leading to destruction of cartilage proteoglycans and type IX collagen (Miller et al. 2009). The levels of PGE2 and MMP-3 in patients with RA are reduced by treatment with glucosamine (Nakamura et al. 2007). A high MMP-3 level is indicative of radiological damage and cartilage degradation (Ally et al. 2013). Supplementation of glucosamine with vitamin E reduced PGE2 and MMP-3 levels in neonatal rats (Dai et al. 2018). In this study, anserine plus glucosamine decreased the level of MMP-3 compared to anserine, glucosamine, and the control. Indeed, the MMP-3 level is reportedly reduced by glucosamine supplementation (Nakamura et al. 2002).

Antioxidants are closely correlated with the levels of oxidants and lipid peroxidation (Gupta et al. 2009). Reduced levels of catalase, SOD, Gpx, and GSH were noted in the control (RA) rats but were restored by anserine plus glucosamine to almost normal ranges. Dai et al. (2018) have reported the glucosamine with vitamin E supplementation restored the levels of catalase, SOD, Gpx, and GSH in neonatal rats. Sugiyama et al. (2005) reported that anserine augments the antitumor activity of doxorubicin. Kang et al. (2002) showed that anserine suppresses peroxyl radical-mediated SOD modification. Dai et al. (2018) reported that vitamin E and glucosamine exert a synergistic therapeutic effect against RA in neonatal rats. Ali et al. (2019) have reported the niclosamide supplementation exert anti-rheumatoid activity in collagen-induced arthritis in rat model. Higher levels of copper and ceruloplasmin (Amancio et al. 2003) and uric acid (Choe and Kim 2015) and a lower level of zinc were noted in rats with RA (Mierzecki et al. 2011), possibly due to an elevated level of IL-1 (Nemeth et al. 2002). Wang et al. (2019) have reported that the curcumin attenuates collagen-induced rat arthritis through apoptotic and anti-inflammatory effects. Researchers have reported that the evodiamine reduces adjuvant-induced arthritis in rats through the inhibition of synovial inflammation and restoring the Th17/Treg balance (Zhang et al. 2020). Supplementation of telmisartan with etanercept attenuates anemia associated with rheumatoid arthritis in rats (Hasanin and Mohamed 2020).

In this study, anserine plus glucosamine restored the levels of copper, ceruloplasmin, and zinc to almost the normal ranges. Taken together, our findings suggest that anserine plus glucosamine supplementation shows therapeutic potential for RA.

Acknowledgements

None.

Authors’ contributions

JM, XC and KC conducted experiments and collected data. QS and KP carried out data interpretation, review of literature and manuscript drafting. All authors read and approved the final manuscript.

Funding

None

Availability of data and materials

Corresponding author could provide the all experimental data on valid request.

Ethics approval and consent to participate

All animal experiments were approved by the ethical committee of Department of Orthopaedics, The Second Affiliated Hospital of Nanchang University, No 1 minde road, Donghu district, Nanchang city, JiangXi province, China, 330000.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Jiang Minghao Zhao and Xiang Chen equally contributed to this work.

Contributor Information

Jiang Minghao Zhao, Email: mdvchp@163.com.

Xiang Chen, Email: exhuce@163.com.

Ke Cheng, Email: tewhcs@163.com.

Qingming Shi, Email: KarynRiveradfc@yahoo.com.

Kun Peng, Email: soygwz@163.com.

References

  1. Ali AG, Faiq G, Ahmed M. The anti-rheumatoid activity of niclosamide in collagen-induced arthritis in rats. Arch Rheumatol. 2019;34(4):426–433. doi: 10.5606/ArchRheumatol.2019.7100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ally MM, Hodkinson B, Meyer PW, Musenge E, Tikly M, Anderson R. Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis. Mediators Inflamm. 2013;2013:183653. doi: 10.1155/2013/183653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Amancio SOM, Chaud ADM, Yanaguibashi G, Esteves Hilario MO. Copper and zinc intake and serum levels in patients with juvenile rheumatoid arthritis. Eur J Clin Nutr. 2003;57:706–712. doi: 10.1038/sj.ejcn.1601601. [DOI] [PubMed] [Google Scholar]
  4. Bae SC, Kim SJ, Sung MK. Inadequate antioxidant nutrient intake and altered plasma antioxidant status of rheumatoid arthritis patients. J Am Coll Nutr. 2003;22:311–315. doi: 10.1080/07315724.2003.10719309. [DOI] [PubMed] [Google Scholar]
  5. Balic MN, Rapp S, Stanzer H, Lin J, Strutz J, Szkandera MG, Daidone H, Samonigg RJ, Cote N. Dandachi, Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells. Appl Immunohistochem Mol Morphol. 2011;19:33–40. doi: 10.1097/PAI.0b013e3181ebf4e8. [DOI] [PubMed] [Google Scholar]
  6. Baydas G, Gursu MF, Yilmaz S, Canpolat S, Yasar A, Cikim G, Canatan H. Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats. Neurosci Lett. 2002;323:195–198. doi: 10.1016/S0304-3940(02)00144-1. [DOI] [PubMed] [Google Scholar]
  7. Choe JY, Kim SK. Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide. Clin Chim Acta. 2015;1(438):29–34. doi: 10.1016/j.cca.2014.07.039. [DOI] [PubMed] [Google Scholar]
  8. Choudhary N, Bhatt LK, Prabhavalkar KS. Experimental animal models for rheumatoid arthritis. Immunopharmacol Immunotoxicol. 2018;40(3):193–200. doi: 10.1080/08923973.2018.1434793. [DOI] [PubMed] [Google Scholar]
  9. Curtis JR, Singh JA. Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin Ther. 2011;33(6):679–707. doi: 10.1016/j.clinthera.2011.05.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dai W, Qi C, Wang S. Synergistic effect of glucosamine and vitamin E against experimental rheumatoid arthritis in neonatal rats. Biomed Pharmacother. 2018;105:835–840. doi: 10.1016/j.biopha.2018.05.136. [DOI] [PubMed] [Google Scholar]
  11. Gupta S, Sodhi S, Mahajan V. Correlation of antioxidants with lipid peroxidation and lipid profile in patients suffering from coronary artery disease. Expert Opin Ther Targets. 2009;13(8):889–894. doi: 10.1517/14728220903099668. [DOI] [PubMed] [Google Scholar]
  12. Hasanin AH, Mohamed RH. Telmisartan alone or in combination with etanercept improves anemia associated with rheumatoid arthritis in rats: a possible role of anti-inflammatory and reno-protective effects. Pharmacol Rep. 2020 doi: 10.1007/s43440-019-00033-w. [DOI] [PubMed] [Google Scholar]
  13. Kaneko J, Enya A, Enomoto K. Anserine (beta-alanyl-3-methyl-l-histidine) improves neurovascular-unit dysfunction and spatial memory in aged AβPPswe/PSEN1dE9 Alzheimer’s-model mice. Sci Rep. 2017;7:12571. doi: 10.1038/s41598-017-12785-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kang JH, Kim KS, Choi SY, Kwon HY, Won MH, Kang TC. Protective effects of carnosine, homocarnosine and anserine against peroxyl radical-mediated Cu, Zn-superoxide dismutase modification. Biochim Biophys Acta. 2002;1570(2):89–96. doi: 10.1016/S0304-4165(02)00158-7. [DOI] [PubMed] [Google Scholar]
  15. Kubomura D, Matahira Y, Nagai K, Niijima A. Effect of anserine ingestion on the hyperglycemia and autonomic nerves in rats and humans. Nutr Neurosci. 2010;13(3):123–128. doi: 10.1179/147683010X12611460764048. [DOI] [PubMed] [Google Scholar]
  16. Liu H, Pope RM. The role of apoptosis in rheumatoid arthritis. Curr Opin Pharmacol. 2003;3:317–322. doi: 10.1016/S1471-4892(03)00037-7. [DOI] [PubMed] [Google Scholar]
  17. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000;283:1469–1475. doi: 10.1001/jama.283.11.1469. [DOI] [PubMed] [Google Scholar]
  18. Mierzecki A, Strecker D, Radomska K. A pilot study on zinc levels in patients with rheumatoid arthritis. Biol Trace Elem Res. 2011;143(2):854–862. doi: 10.1007/s12011-010-8952-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Miller MC, Manning HB, Jain A. Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis. Arthritis Rheum. 2009;60(3):686–697. doi: 10.1002/art.24331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nakamura H, Shibakawa A, Tanaka M, Kato T, Nishioka K. Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide, and metalloproteases by chondrocytes and synoviocytes in osteoarthritis. Clin Exp Rheumatol. 2002;22:293–299. [PubMed] [Google Scholar]
  21. Nakamura H, Masuko K, Yudoh K, Kato T, Kamada T, Kawahara T. Effects of glucosamine administration on patients with rheumatoid arthritis. Rheumatol Int. 2007;27:213–218. doi: 10.1007/s00296-006-0197-1. [DOI] [PubMed] [Google Scholar]
  22. Nemeth I, Talosi G, Papp A, Boda D. Xanthine oxidase activation in mild gestational hypertension. Hypertens Pregnancy. 2002;21:1–11. doi: 10.1081/PRG-120002905. [DOI] [PubMed] [Google Scholar]
  23. Ozturk HS, Cimen MY, Cimen OB, Kacmaz M, Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int. 1999;19:35–37. doi: 10.1007/s002960050097. [DOI] [PubMed] [Google Scholar]
  24. Reginster J, Deroisy Y, Rovati R, Lee LC, Lejeune RL, Bruyere E, Giacovelli O, Henrotin G, Dacre Y, Gossett JE. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet. 2001;357:251–256. doi: 10.1016/S0140-6736(00)03610-2. [DOI] [PubMed] [Google Scholar]
  25. Samarghandian S, Azimi-Nezhad M, Samini F. Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus. Biomed Res Int. 2014;9:208–257. doi: 10.1155/2014/920857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sugiyama T, Hatakeyama H, Inoue C, Sadzuka Y. The effect of anserine, a novel biochemical modulator, on the antitumor activity of doxorubicin. Cancer Res. 2005;65:9. [Google Scholar]
  27. Tanida M, Shen J, Kubomura D, Nagai K. Effects of anserine on the renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats. Physiol Res. 2010;59(2):177–185. doi: 10.33549/physiolres.931623. [DOI] [PubMed] [Google Scholar]
  28. Tiku ML, Narla H, Jain M, Yalamanchili P. Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipoxidation reactions and protein oxidation. Arthritis Res Ther. 2007;9(4):R76. doi: 10.1186/ar2274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, Hochberg MC, Wells G. Glucosamine for osteoarthritis. Cochrane Database Syst Rev. 2005;2:CD002946. doi: 10.1002/14651858.CD002946.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Van Beezooijen RL, Que I, Ederveen AG, Kloosterbor HJ. Plasma nitrate + nitrite level are regulated by ovarian steroids but do not correlate with trabecular bone mineral density in rats. J Endocrinol. 1998;159:27–34. doi: 10.1677/joe.0.1590027. [DOI] [PubMed] [Google Scholar]
  31. van Vugt RM, Rijken PJ, Rietveld AG, van Vugt AC, Dijkmans BA. Antioxidant intervention in rheumatoid arthritis: results of an open pilot study. Clin Rheumatol. 2008;27(6):771–775. doi: 10.1007/s10067-008-0848-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Verschueren P, Esselens G, Westhovens R. Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study. Scand J Rheumatol. 2009;38(3):166–172. doi: 10.1080/03009740802484846. [DOI] [PubMed] [Google Scholar]
  33. Wang K, Zhao L, Liu X, Hao Z, Zhou Y, Yang C, Li H. Differential co-expression analysis of rheumatoid arthritis with microarray data. Mol Med Rep. 2014;10:2421–2426. doi: 10.3892/mmr.2014.2491. [DOI] [PubMed] [Google Scholar]
  34. Wang Y, Lu Y, Wang J, Shen Z, Liu H, Ma W, Zhang J, Ma X, Wang K, Meng F. Preparation and analysis of active rat model of rheumatoid arthritis with features of TCM toxic heat-stasis painful obstruction. J Tradit Chin Med Sci. 2015;2(3):166–172. [Google Scholar]
  35. Wang Q, Ye C, Sun S, Li R, Shi X, Wang S, Zeng X, Kuang N, Liu Y, Shi Q, Liu R. Curcumin attenuates collagen-induced rat arthritis via anti-inflammatory and apoptotic effects. Int Immunopharmacol. 2019;72:292–300. doi: 10.1016/j.intimp.2019.04.027. [DOI] [PubMed] [Google Scholar]
  36. Weydert CJ, Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc. 2010;5(1):51–66. doi: 10.1038/nprot.2009.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wu HC, Shiau CY, Chen HM, Chiou TK. Antioxidant activities of carnosine, anserine, some free amino acids and their combination. J Food Drug Anal. 2003;11:148–153. [Google Scholar]
  38. Wu Y, Wang Y, Ou J. Effect and mechanism of ShiZhiFang on uric acid metabolism in hyperuricemic rats. Evid Based Complement Alternat Med. 2018;2018:6821387. doi: 10.1155/2018/6821387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Zhang H, Yin L, Lu M, Wang J, Li YT, Gao WL, Yin ZS. Evodiamine attenuates adjuvant-induced arthritis in rats by inhibiting synovial inflammation and restoring the Th17/Treg balance. J Pharm Pharmacol. 2020 doi: 10.1111/jphp.13238. [DOI] [PubMed] [Google Scholar]
  40. Zou L, Zhang G, Liu L, Chen C, Cao X, Cai J. Relationship between PI3K pathway and angiogenesis in CIA rat synovium. Am J Transl Res. 2016;8(7):3141–3147. [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Corresponding author could provide the all experimental data on valid request.

Articles from AMB Express are provided here courtesy of Springer-Verlag

RESOURCES